Mid-Atlantic Diamond Ventures was founded asDiamond State Ventures by a group of entrepreneurs and business leaders from the greater Wilmington, DE region in 2003. The program was brought to the Fox School of Business at Temple University in January 2006 based on the school's reputation for excellence in entrepreneurship. A special thank you goes out to our dedicated Advisory Board which provides programmatic direction, networking connections, counsel and coaching to emerging firms served by MADV:
* Executive Committee Member
Senior Entrepreneurship Facilitator: ADAM GITZES
BIOS of MADV advisory board members
Principal, DGK Group, PC
Tom is a seasoned Chief Financial Officer with over thirty years of extensive and broad business experience as a proactive leader and key member of senior leadership teams in high tech industries. His expertise includes international acquisitions and merger negotiations, initial public offerings, start-up systems development, change management and corporate restructuring, SEC reporting, and financial consulting.
Tom is a Principal at DGK Group, a regional public accounting firm that provides high quality tax, accounting, and outsourced financial management consulting to small and middle market companies. Tom serves in the capacity of business development for the firm and as a CFO consultant for emerging growth companies. In his position he is responsible for providing advice to CEOs, preparing financial presentations, business and operating plans and implementing financial systems. Prior to joining the DGK Group, P.C. in 2007 Tom was the Senior Vice President and Chief Financial Officer of Prescient Applied Intelligence, a public software company. From 2002 to 2005 he was the Vice President and Chief Financial Officer of Lamina Ceramics Inc., a technology spin-out from Sarnoff Corporation. From 2000 to 2002 Tom was the Senior Vice President and Chief Financial Officer of Sychip, Inc. a technology venture of Lucent Technologies. From 1996 to 2000 he was the Senior Vice President and Chief Financial Officer of GMT Microelectronics Corporation, a semiconductor company. Prior to 1996 Tom served as the Chief Financial Officer of technology companies Teleos Communications Inc., Gandalf Systems Corporation and Infotron Systems Corporation. Tom has also held accounting and finance positions with Ford Aerospace and General Electric, and served in the U.S. Army.
Tom earned his Bachelor’s degree in Business Administration from Virginia Southern College. He is a member of the Institute of Management Accountants, Greater Philadelphia Senior Executive Group, in which he is the Co-chair of the Financial Executives Subgroup, and is a member of the Financial Executives Networking Group.
Executive Chairman, Rapid Micro Biosystems
Mr. Cashman is a co-founder of Protez Pharmaceuticals Inc. and most recently served as Director, President and CEO. Protez was acquired by Novartis in 2008. He has 30 years experience in the pharmaceutical industry including prior roles as President and CEO, Message Pharmaceuticals, and as Vice President, Sales and Marketing, for both Pfizer and SmithKline Beecham. Mr. Cashman also serves on the board of directors of the Science Center, Noble Biomaterials, Marinus Pharmaceuticals and MBF Therapeutics.
Founder and CEO, Alcyone*7
Dr. Tama Copeman is the founder and CEO of Alcyone*7, a management advisory company, and the founder and Managing Partner of Maya*7 Investments, an associated boutiqueinvestment company. Tama has over 35 years experience in executive-level strategy and risk, business development, general management and operations, governance, ventures and equity investments, international partnerships, technology and product development, intellectual property strategy and competitive analysis, and human capital.
Tama has worked with and for numerous companies ranging from start up to Fortune 500 in the US and Europe. Alcyone*7, founded in 2004, has domain expertise in energy, clean technology and physical sciences. Maya*7 Investments has a growing investment base in biotechnology and medical devices. Over the years, Tama has taken many products to market and has managed product portfolios supporting businesses with total revenue of about $ 1 billion and intellectual property valued in excess of $ 200 MM.
Dr. Copeman holds MS., and Ph.D. degrees in Chemical Engineering from Lehigh University, a BS degree from Penn State University, and has completed executive education courses at Stanford, MIT, and the University of Chicago. Tama is a member of the National Association of Corporate Directors.
Managing Director, BSG Advisors
Ben is the founder of BSG Advisors, a consulting firm with a practice focused on providing financial and operating management expertise to emerging growth and middle market companies, particularly in the technology, life sciences, and advanced manufacturing industries. He serves these clients as an interim or part-time CFO and/or COO, or on a project or transaction, such as an acquisition or divestiture, due diligence, profitability analysis and improvement, cash flow management, turnaround and crisis management, financing, or systems selection and implementation. He also performs due diligence for early stage investors and assists them in transactions.
Prior to founding BSG Advisors, Ben served as CFO of a $20 million manufacturer of packaging materials and a $25 million manufacturer of bar code scanning equipment. As CFO of the bar code scanning manufacturer, he served as a key member of a team that prepared the registration statement and prospectus for the company's initial public offering effort. His experience includes both high growth situations and successful turnarounds. Earlier in his career, he worked for several Fortune 100 companies in positions in Engineering, Operations, and Financial Management. He also taught in the Graduate Business School at Fairleigh Dickinson University.
Ben received his Bachelor's degree in Industrial Engineering from Lehigh University and his Master’s degree in Business Administration from the University of Delaware. He is active in a number of civic and charitable organizations and is a member of the Greater Philadelphia Senior Executives Group, Regional Biotech Council, MidAtlantic Angel Group, and Financial Executive Networking Group.
Partner, Morgan Lewis
Andrew Hamilton is a partner in Morgan Lewis's Business and Finance Practice. Mr. Hamilton practices in the areas of mergers and acquisitions, private equity and venture capital, securities law, and general corporate counseling. Mr. Hamilton has represented both public and private companies in a wide array of industries, including telecommunications, distribution, manufacturing, healthcare services, computer software, information technology, business services, publishing, and transportation. Mr. Hamilton's transactional work is focused on mergers and acquisitions and private equity and venture capital transactions, although he regularly advises clients in all aspects of their growth cycle, from business plan development and startup structuring to exit strategies, including initial public offerings and change in control transactions.
In addition to transactional matters, Mr. Hamilton frequently functions as outside general counsel on behalf of clients with a large part of his practice being devoted to general corporate counseling, including corporate governance matters, board of director and fiduciary duty issues, Sarbanes-Oxley compliance, and related issues. In addition, Mr.
Hamilton spends a significant amount of time working closely with colleagues in other substantive practice areas, such as employee benefits and executive compensation, labor and employment law or intellectual property law, to ensure the delivery of expert legal advice that is carefully coordinated with a client's business objectives.
Many of Mr. Hamilton's clients are private equity or venture backed companies and rely on him both for his experience in handling transactional matters and for continuing guidance on general corporate matters.
Mr. Hamilton received his J.D. from the University of Pennsylvania Law School in 1993. Prior to attending law school, Mr. Hamilton worked for a startup healthcare company located in Exton, Pennsylvania. He received his B.A. from the University of Notre Dame in 1988.
Mr. Hamilton is admitted to practice in Pennsylvania.
Vice President, Investment Group, Ben Franklin Technology Group - Southeastern Pennsylvania
Terrence H. Hicks is Vice-President, Investment Group at the Ben Franklin Technology PArtners of Southeastern Pennsylvania (BFTP/SEP). The Ben Franklin Technology PArtners is a State of Pennsylvania supported economic development corporation that supports the development of technology-based enterprises through a variety of investment programs and technology services. Mr. Hicks is responsible for all of the organization’s investment activities, including investment portfolio strategy, programming, client development and strategic planning, and has served in that capacity for over 16 years. BFTP/SEP has a portfolio of over 120 early and emerging stage technology companies; one of the largest such portfolios in the country. BFTP/SEP was recently recognized as the third most active venture capital firm for seed and early stage companies in Entrepreneur Magazine’s Top 100 Venture Capital Firms for Early Stage Companies.
Mr. Hicks came to the Ben Franklin Technology PArtners in November, 1993 after twenty years of experience in small business lending and corporate treasury activities with Fidelity Bank (currently Wells Fargo) and Sun Company respectively. Mr. Hicks previously served as Vice President of Sun Company's Specialized Small Business Investment Company. He also served in numerous financial management positions at Sun, including manager of internal treasury operations and manager of special projects.
Mr. Hicks has a BA in economics from Swarthmore College and an MBA from LaSalle University. He serves on the advisory board of the Mid-Atlantic Diamond Ventures program and is a founder of the Minority Angel Investor Network, the nation’s only organized network of angel investors focused on investments in high-growth minority owned or led businesses.
Partner, Pepper Hamilton LLP
Michael K. Jones is a partner in the Philadelphia and Princeton offices of Pepper Hamilton LLP and a member of the firm’s Intellectual Property Practice Group. He also is a member of the firm’s Life Sciences Practice Group and the Sustainability, CleanTech and Climate Change Team.
A registered patent attorney, Mr. Jones’ practice focuses on all aspects of intellectual property and he has particular experience in strategic intellectual property counseling and portfolio management, patent procurement (including domestic and foreign rights), opinions, due diligence, licensing, and enforcing and defending IP rights.
Mr. Jones has experience working with early stage technology companies and entrepreneurs to help develop, enhance and protect their innovations. Mr. Jones is active in both the entrepreneur community and the investment community, and regularly connects those in need of funding with appropriate sources of funding.
Mr. Jones has counseled clients in a variety of industries and in a wide range of technologies, including mechanical and electrical devices, electronics, communication systems, computer hardware, data collection and storage systems, content conditioning and delivery systems, electrical connectors, robotics and automated systems, medical devices, clean technologies, consumer products, clothing apparel, biometrics, optics, printing and imaging systems, vessel design and construction, watercraft propulsion and auxiliary systems, manufacturing techniques, packaging, advanced materials and business methods.
Executive Director, and Senior Executive in Residence Innovation and Entrepreneurship Institute and Mid-Atlantic Diamond Ventures, Fox School of Business, Temple University
Jaine Lucas is the executive director of the Innovation and Entrepreneurship Institute (IEI) and MidAtlantic Diamond Ventures (MADV). During her career, Jaine has been a marketing and branding executive, entrepreneur and business owner, creative writer and polymer chemist. She has worked for and with start-ups and Fortune 1000 companies across many industries in strategic, creative and general management roles.
At Temple, Jaine's areas of expertise in the entrepreneurship space include ideation, strategy, women's entrepreneurship, business planning and funding of start-ups ventures, and she speaks frequently on these topics. She has been quoted extensively in the press, including the PBS, the Philadelphia Inquirer, Executive Leaders Radio, Philadelphia Business Journal and others.
Prior to Temple, Jaine founded and provided strategic marketing and operations leadership for a start-up specialty apparel company targeting female sports fans. At Sunoco, a Fortune 50 company, she led brand management for the Retail Marketing division (over 4,500 gasoline and 800 convenience stores), including launching and managing the company’s NASCAR sponsorship. Jaine also managed brand marketing and communications, credit card sales, customer service, and directed the operations of the Sunoco private label credit card center. She was a global communications leader with GE Plastics where she championed external and internal communications. In the 1990s, she developed and operated an award-winning boutique marketing firm, Lucas & Partners, built on a novel business model. Her prior agency experience includes The Weightman Group (Philadelphia) and a division of Chiat Day (New York) where she developed integrated marketing programs for large national B2B clients. Her agency work earned numerous awards for creativity and effectiveness from the NY One Club of Advertising, Addys, BMA Bell Ringers, Art Director’s Club of Philadelphia, Most Memorable Ads and Readex.
Ms. Lucas holds a MS in Analytical Chemistry from the University of Illinois (Urbana-Champaign) and graduated summa cum laude and with University Honors in Chemistry from Fairleigh Dickinson University.
She is a member of the board of directors for Ulysses Venture Partners (NYC, the Entrepreneurs Forum of Greater Philadelph, and the America-Israel Chamber of Commerc, and is a member of the University City Science Center Community Charter Committee. She is an advisory board member for the Fox School of Business' MBA and iMBA Consulting Practicums. Jaine serves as chair of Temple's Council on Entrepreneurship and is a co-Leader of its League for Entrepreneurial Wome. She is a member of the Union League of Philadelphia, the Forum of Executive Women, the Greater Philadelphia Senior Executive Group, and the Alliance of Women Entrepreneurs (AWE). She is a passionate advocate for those with autism and their families, and served as a member of the board of the Center for Autistic Children for over 13 years.
Marketing, CBIZ Accounting, Tax & Advisory Services, LLC
A 15 year veteran of marketing and business development for theaccounting and legal professions, Mark directs the firm’s marketing initiatives and business development efforts for CBIZ MHM, LLC, the Philadelphia area’s 6th largest accounting provider.
A lead member for the firm’s National Investment Capital Practice, Mark is responsible for fostering mutually-beneficial working relationships with investment professionals, attorneys, bankers and various economic development and industrial organizations. Additionally, Mark is responsible for connecting entrepreneurs with various capital sources and advisors. Prior to CBIZ, Mark was responsible for member relations with the PICPA (Pennsylvania Institute of Certified Public Accountants). Additionally, Mark spent many years in sales, marketing, production and operations in legal publishing for both Thomson West Law’s Andrews Publications and LRP Publications. Nationally, Mark has assisted entrepreneurs develop commercialization strategies, serving as a Mentor for companies currently enrolled in the National Institute of Health’s Commercialization Access Program (NIH-CAP) administered Mark has served as the Co-Chair of the Philly 100 Awards from 2007-2010 and is active in many regional organizations. A member of the Steering Committee and Co-Chair of the Marketing Committee for IMPACT 2010 and serves on the Board of Directors for the Entrepreneur’s Forum . Mark is also a member of the Marketing Committee for ACG Philadelphia and has assisted with various events and organizations including the Pennsylvania Angel Network, Angel Venture Fair, Maryland TEDCO, Ben Franklin Emerging Business Awards among many others.
Mark received his Bachelor of Science in Journalism from West Virginia University and currently resides in suburban Philadelphia with his wife and two children.
Daniel Monaco is a partner in the firm's Intellectual Property Practice Group. Formerly a shareholder with the Philadelphia intellectual property law firm of Seidel, Gonda, Lavorgna & Monaco, P.C., Dan joined Drinker Biddle & Reath when the two firms combined practices in 2001. He has been a registered patent attorney since 1981.
Intellectual Property. Dan has extensive experience in all aspects of intellectual property law. Concentrating on patent practice, Dan has prepared and prosecuted hundreds of U.S. patent applications, primarily in chemistry and biotechnology. He has represented diverse business and academic clients in matters pertaining to chemistry and chemical engineering. Representative chemical technologies include polymers, high performance coatings, chemical formulations, forestry products and industrial chemical processes; human and veterinary health care products, particularly pharmaceuticals such as anticancer, antithrombotic and antiviral drugs; methods and compositions for liquid lung ventilation in neonates; dental products; controlled delivery of pharmaceuticals, such as transdermal drug delivery; and diagnostic in vivo imaging of tumors and thrombi.
Dan has also represented clients in a broad spectrum of biotechnology applications from anticancer therapies and biopharmaceuticals to molecular genetics/biology and clinical diagnostics. Representative biological technologies include immunology; cancer vaccines, for example genetically engineered antitumor cellular immunogens; antisense oligonucleotide therapies; gene therapies, particularly targeted alteration of genes to correct genetic defects; nuclear transfer, cloning and the production of transgenic animals; generation of null mutant transgenic animals as disease models; monoclonal antibody technologies; genetic engineering of microorganisms; molecular genetic-based diagnostic methods; novel DNA and expressed proteins; peptide drugs, particularly antithrombotic and anticancer drugs; artificial blood substitutes; and agrobiotechnology.
Dan has represented major academic and business clients, individuals and startup companies in the Delaware Valley and elsewhere, before the United States Patent and Trademark Office and the federal courts. He has also prepared and negotiated numerous agreements involving the licensing of intellectual property rights. Working through an extensive network of overseas associates, Dan has counseled clients extensively in international patent protection, and has obtained extensive foreign patent protection for a wide variety of clients. He has also served as an expert witness during biotechnology litigation.
Publications. Dan is the co-author of What the General Practitioner Should Know About Patent Law and Practice, American Law Institute – American Bar Association Committee on Continuing Professional Education.
In General. Dan is a member of the Philadelphia, Pennsylvania and American Bar Associations, the American Intellectual Property Law Association, and the American Chemical Society.
Daniel has been ranked by Chambers USA since 2004 in Intellectual Property Law, recognizing him as "a skilled attorney who is great at building client relationships."
Bob Moul is a Philadelphia tech CEO / entrepreneur with 30 years experience in the hi-tech industry ranging from start-ups to Fortune 50 companies. He began his career out of high school in the mailroom at EDS and over the course of 19 years was rapidly promoted to senior management positions including global account executive for EDS UK, director of operations for EDS Hong Kong and China, and executive director of federal government operations for EDS Australia.
At Systems and Computer Technology (SCT – the global higher education software leader) in Malvern, Bob ran the company’s $100mm outsourcing business and later the $300mm education solutions business where he led the company to 10 consecutive record quarters of growth prior to being acquired by SunGard for $650mm. The company was recently acquired again for $1.7 billion. Bob was also group president at MAXIMUS where he was responsible for five divisions of this $700mm consulting company including two software businesses.
Bob left the corporate world in 2004 and founded VentureWerks LLC, a venture advisory firm, where he consulted to numerous venture-backed startups including Intelliworks, Rave Wireless, and Provost Systems (acquired by Edison Learning). He later joined Berwyn-based Boomi in 2005 as a member of the board of directors and was appointed president and CEO in August 2006. He raised the company’s first venture capital and led its successful transformation from a traditional software product company to a leading cloud computing infrastructure provider culminating in a highly successful exit to Dell in November 2010.
While at EDS, Bob graduated from the University of Maryland, University College, with a Master of Science degree in technology management. He also completed executive programs at the Stephen M. Ross School of Business at the University of Michigan and the Center for Organizational Learning at MIT. Bob is an active advocate for driving tech innovation and entrepreneurship in Philadelphia. He serves on the board of directors of Bluenog Software and the advisory board of Mid-Atlantic Diamond Ventures at Temple University’s Fox School of Business and is a member of the Philadelphia Alliance of Capital and Technology. He is a frequent speaker and panelist at SaaS and cloud computing conferences and has been interviewed on related topics for numerous business journals including Forbes, InformationWeek, ComputerWorld, and InfoWorld. Bob is a 2007 alumnus of DC-based Mindshare (an invitation-only start-up CEO forum) and was recently named a 2011 Ernst & Young Entrepreneur of the Year finalist in Philadelphia.
Partner, MVP Capital Partners
Mr. Penn joined MVP in 2000 from Boston Millennia Partners, a private equity firm where he was a Partner. He has served on numerous MVP company boards including Andrews International, Coffin Turbo Pump, and Implex.
From 1994 to 1998, Mr. Penn was President and CEO of Tektagen, Inc., a leading contract services firm serving the biotechnology and pharmaceutical industries. Tektagen was successfully sold to Charles River Laboratories, Inc. in 1998. Prior to Tektagen, Mr. Penn was President of Independence Ventures, Inc., a firm that specialized in starting and building high-potential, technology-based companies. Earlier in his career he held several positions in industry and venture capital.
Mr. Penn is a graduate of the Massachusetts Institute of Technology, the Stanford University Graduate School of Business, and the University of Pennsylvania Law School.
Founder and Managing Partner, CapGenic Advisors, LLC
Bernard C. Rudnick is Founder and Managing Partner of CapGenic Advisors, LLC. He has 36 years of experience in executive-level strategy, finance, and management. Bernie has senior merger, acquisition, capitalization leadership experience with companies ranging from start-up to Fortune 50. He has held positions of CEO, COO, President, and Executive Vice President in a number of companies, and has been transactional as a financial advisor to McKesson, Mitsui and many more. He was a founder and President of West Consumer Electronics, a business with revenues exceeding $60M that achieved market leadership. As founder and COO of RMI Financial Services, the business grew from start-up to a firm with $600M in sales.
With substantial experience investing and guiding investments in entrepreneurial companies Bernie has led capital formation totaling over $380M in the past six years and $3B over the last 15 years. He is a founding member and Chairman Emeritus of Mid Atlantic Diamond Ventures within the Fox School of Business. Corporate and charitable board service includes Vice Chairman, Delaware and Maryland Eastern Shore March of Dimes, Director, Perinatal Board of the State of Delaware, Director and CFO of GTAC, Director of GrantAdler, Observer and CFO of Immunomic Therapeutics, Director and CFO of Tinnitus Otosound Products.
Mr. Rudnick recently completed a refinancing for Promosome, a cell line engineering company, led by the scientific tem of Nobel Laureate Gerald Edelman. He has served as an advisor to NGN Capital in designing and facilitating investment portfolio exits. Focused on Healthcare and Software, Mr. Rudnick led the merger of Postgraduate Institute for Medicine into Jobson Publishing, Inc. to create one of the first on-line venues for professional medical continuing education and certification. He co-led of the HealthStar Communications team which facilitated and funded a $250M industry consolidation in the medical marketing sector. He led the sale and recapitalization of a Mitsui subsidiary, Mitrix and the merger of its new incarnation, Amitive. Bernie currently advises companies in the clinical software space, therapeutic, medical device, and in the cell line engineering areas.
Bernie received his BS in Biochemistry from Pennsylvania State University and was conferred a MA in administration at Northwood University.
Partner, Ashton Tweed
Jordan Warshafsky has more than 25 years of experience within the pharmaceutical, biotechnology, and medical device sectors of the Life Sciences industry. He has held corporate and division level leadership positions in business development, global marketing and strategic planning. In addition to being responsible for P&L goals for early stage and mature organizations, Jordan has extensive marketing/sales, market research, and licensing/acquisition experience. He has also completed strategic acquisitions for public and private companies.
Prior to joining as a Partner of Ashton Tweed, Jordan served as President and Director of TYRX, Inc., a biotechnology company specializing in polymer drug delivery. Before that, he served as the Vice President, Strategic Development for Integra LifeSciences, a maker of medical and biotech devices.
Jordan has significant big pharma management experience and previously served as Associate Director, Worldwide Franchise Management at Bristol–Myers Squibb. In that position, Jordan was responsible for the worldwide management of hospital anti-infective products. He was also Senior Manager, Worldwide Product and Market Planning, Wound & Skin Care, ConvaTec (a division of Bristol-Myers Squibb) where he was responsible for the acquisition and in-licensing of wound care products and companies.
Jordan is an active participant and leader in a number of life science industry organizations such as BioNJ, PA Bio, Mid-Atlantic Diamond Ventures (MADV), Pharmaceutical Consulting Consortium International (PCCI), Philadelphia Alliance for Capital and Technologies (PACT), AdvaMed, American Israeli Chamber of Commerce (AICC), Greater Philadelphia Senior Executives Group (GPSEG), BioStrategy Partners, and others.
Jordan holds an MBA and a BS in Earth Science.
Partner, SCP Partners
Wayne has been a partner of SCP Partners since its inception and has been involved with private equity and venture capital investing since 1987. SCP is one of the largest venture capital operations in Pennsylvania, with over $1 billion under management in several funds. Wayne is co-founder and managing director of SCP Vitalife Partners, an Israel/U.S. venture fund focused on medical technology. He is also a member of the board of directors of CIP Capital L.P., an SBIC which he helped found in 1990.
Wayne is a director or chairman of several companies, including Grab Networks, Echo 360, Gigared, Deep Breeze, Trig Medical, Recro Pharma, Garnet Biotherapeutics, Endospan, and Argo Medical Technologies. He also serves on the investment committee of Vitalife Life Sciences Fund. From 1992 to 1994, Wayne served as executive vice president of Affinity Biotech, Inc., a drug delivery company, where he was responsible for strategic alliances, financial strategy, and mergers and acquisitions. He also oversaw its IPO and merger into the company that subsequently became IBAH, Inc., a leading contract research organization. From 1987 to 1990, Wayne operated a management and financial advisory firm. Wayne began his career at the Philadelphia law firm of Saul, Ewing, Remick & Saul.
Wayne received his B.A. cum laude from the University of Pennsylvania and his J.D. from the University of Michigan Law School. He is on the boards of several organizations, including the Young Scholars Charter School where he is a member of the executive committee.
Assistant Professor of Strategic Management and Entrepreneurship, Fox School of Business, Temple University
Sheryl Winston-Smith is an Assistant Professor of Strategic Management and Entrepreneurship at Temple University. Sheryl's academic training includes a bachelor's degree from Yale University in Biology and History, her MPA degree from the John F. Kennedy School of Government of Harvard University and her Ph.D. from Harvard University.
Her areas of expertise and interest include: technology-related entrepreneurship, entrepreneurial finance, venture capital and corporate venturing, international entrepreneurship, and the economics of innovation, strategy and competitive advantage. Her current research includes empirical research on entrepreneurship and innovation in the medical device industry.
Sheryl has held academic positions at the Sloan School of Management, MIT as well as the Carlson School of Management, University of Minnesota. Sheryl has been the recipient of numerous fellowships and awards and brings with her several years of professional experience in the private and public sectors.
Senior Entrepreneurship Facilitator, Fox School of Business, Temple University
Adam Gitzes is a Master’s candidate for Financial Engineering at the Fox School of Business. Adam’s undergraduate degree is in actuarial science and he has passed two actuarial exams while in school.
Adam has a significant amount of experience working in the service and financial industries including an internship position with Montgomery Investment Technology. He has become a member of the growing tech community in Philadelphia and is on the board of the student organization NVigor. Upon completion of his Master's program he will join Lincoln Financial's Leadership Preparation Program in the Web Analytics department.